Impact of COVID-19 on pre-existing liver disease

被引：0

作者：

Abdo-Francis, Juan M. ^{[1
]}

Moreno-Alcantar, Rosalba ^{[2
]}

Perez-Hernandez, Jose L. ^{[3
]}

Remes-Troche, Jose M. ^{[4
]}

Velasco, Antonio Velarde-Ruiz ^{[5
]}

Cerda-Reyes, Eira ^{[6
]}

de la Tijera, Fatima Higuera ^{[3
]}

Castro-Narro, Graciela ^{[7
]}

机构：

[1] Hosp Angeles Acoxpa, Serv Gastroenterol, Mexico City, DF, Mexico

[2] Hosp Especialidades Ctr Med La Raza, Ctr Med Nacl Siglo 21, Serv Gastroenterol, IMSS, Mexico City, DF, Mexico

[3] Hosp Gen Mexico City, Serv Gastroenterol, Mexico City, DF, Mexico

[4] Inst Invest Biol, Veracruz, Mexico

[5] Hosp Civil, Serv Gastroenterol, Guadalajara, Jalisco, Mexico

[6] Hosp Cent Mil, Clin Higado, Mexico City, DF, Mexico

[7] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Serv Gastroenterol, Mexico City, DF, Mexico

来源：

CIRUGIA Y CIRUJANOS | 2024年 / 92卷 / 01期

关键词：

Pre-existing liver disease; COVID-19; COVID and cirrhosis; MANIFESTATIONS; CORONAVIRUS; ACE2; RISK;

D O I：

10.24875/CIRU.23000409

中图分类号：

R61 [外科手术学];

学科分类号：

摘要：

Patients with chronic liver disease of any etiology who become infected with SARS-CoV-2 have been found to have a higher risk of mortality compared to those patients who do not have chronic liver disease. A literature review was conducted in the relationship between COVID 19 and preexistence of liver disease. The proportion of COVID-19 patients with abnormal liver function on admission ranged from 40 % to 75 % and the proportion with liver injury was close to 30%. Current studies show an important association between preexisting liver disease and COVID-19. The presence of cirrhosis is now an independent predictor of severity for COVID-19 and prolonged hospitalization in this group of patients. Patients with cirrhosis have a higher mortality rate, and this rate rises with increasing severity.

引用

页码：131 / 136

页数：6

共 40 条

[1] COVID-19: Current Status in Gastrointestinal, Hepatic, and Pancreatic Diseases-A Concise Review [J].

Aquino-Matus, Jorge ;

Uribe, Misael ;

Chavez-Tapia, Norberto .

TROPICAL MEDICINE AND INFECTIOUS DISEASE, 2022, 7 (08)

[2]

Bajaj J, 2020, Gut, DOI [10.1136/gutjnl-2020-3221180:1-6, DOI 10.1136/GUTJNL-2020-3221180:1-6]

[3] COVID-19 and comorbidities: A role for dipeptidyl peptidase 4 (DPP4) in disease severity? [J].

Bassendine, Margaret F. ;

Bridge, Simon H. ;

McCaughan, Geoffrey W. ;

Gorrell, Mark D. .

JOURNAL OF DIABETES, 2020, 12 (09) :649-658

[4] Endocrine and metabolic link to coronavirus infection [J].

Bornstein, Stefan R. ;

Dalan, Rinkoo ;

Hopkins, David ;

Mingrone, Geltrude ;

Boehm, Bernhard O. .

NATURE REVIEWS ENDOCRINOLOGY, 2020, 16 (06) :297-298

[5] Liver fibrosis in patients with metabolic associated fatty liver disease is a risk factor for adverse outcomes in COVID-19 [J].

Campos-Murguia, Alejandro ;

Monserrat Roman-Calleja, Berenice ;

Vicente Toledo-Coronado, Israel ;

Alberto Gonzalez-Regueiro, Jose ;

Adrian Solis-Ortega, Alberto ;

Kusulas-Delint, Deyanira ;

Cruz-Contreras, Mariana ;

Cruz-Yedra, Nabila ;

Javier Cubero, Francisco ;

Alexandrowna Nevzorova, Yulia ;

Fernando Martinez-Cabrera, Carlos ;

Moreno-Guillen, Paulina ;

Arturo Lozano-Cruz, Oscar ;

Chapa-Ibarguengoitia, Monica ;

Gulias-Herrero, Alfonso ;

Alberto Aguilar-Salinas, Carlos ;

Ruiz-Margain, Astrid ;

Ulises Macias-Rodriguez, Ricardo .

DIGESTIVE AND LIVER DISEASE, 2021, 53 (05) :525-533

[6] Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study [J].

Chen, Nanshan ;

Zhou, Min ;

Dong, Xuan ;

Qu, Jieming ;

Gong, Fengyun ;

Han, Yang ;

Qiu, Yang ;

Wang, Jingli ;

Liu, Ying ;

Wei, Yuan ;

Xia, Jia'an ;

Yu, Ting ;

Zhang, Xinxin ;

Zhang, Li .

LANCET, 2020, 395 (10223) :507-513

[7]

Chen Xingdong., 2020, MEDRXIV, DOI [DOI 10.1093/CID/CIAA449, DOI 10.1101/2020.02.29.20029520]

[8] Adipose tissue dysfunction and MAFLD in obesity on the scene of COVID-19 [J].

Cordeiro, Adryana ;

Ribamar, Amanda ;

Ramalho, Andrea .

CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2022, 46 (03)

[9] Obese patients with NASH have increased hepatic expression of SARS-CoV-2 critical entry points [J].

Fondevila, Marcos F. ;

Mercado-Gomez, Maria ;

Rodriguez, Amaia ;

Gonzalez-Rellan, Maria J. ;

Iruzubieta, Paula ;

Valenti, Victor ;

Escalada, Javier ;

Schwaninger, Markus ;

Prevot, Vincent ;

Dieguez, Carlos ;

Crespo, Javier ;

Fruehbeck, Gema ;

Martinez-Chantar, Maria L. ;

Nogueiras, Ruben .

JOURNAL OF HEPATOLOGY, 2021, 74 (02) :469-471

[10] Metabolic associated fatty liver disease increases coronavirus disease 2019 disease severity in nondiabetic patients [J].

Gao, Feng ;

Zheng, Kenneth, I ;

Wang, Xiao-Bo ;

Yan, Hua-Dong ;

Sun, Qing-Feng ;

Pan, Ke-Hua ;

Wang, Ting-Yao ;

Chen, Yong-Ping ;

George, Jacob ;

Zheng, Ming-Hua .

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 (01) :204-207

← 1 2 3 4 →